Cuba is currently registering the highest number of positive cases of COVID-19 since the outbreak of the pandemic. The Temporary Working Group for the control and prevention of the disease updated the medical protocol to be implemented in positives, suspects and contacts.

The Cuba Solidarity Movement in the United States reaffirmed its commitment to the Caribbean nation and announced the success of the campaign to send six million vaccination syringes.

Experts with the Pan-Am Health Organization—PAHO, and the World Health Organization –WHO, along with Cuban scientists considered the efficacy results of the Cuban COVID-19 vaccine Abdala and candidate vaccines Soberana 02 and Soberana Plus.

Cuba has reported the largest numbers of children infected with SARS-Cov-2 over the past few days and even when most of them are progressing favorably, there is the risk to develop long-time aftereffects.

The Provincial Division of Public Health in the province of Holguín is already implementing new isolation protocols for SarsCOV-2 suspected and positive cases, in keeping with the in-home care procedures established in view of the high transmission levels in several Cuban provinces.

Authorities in the special municipality of the Isle of Youth, to the southwest of Cuba’s mainland, will ease COVID-19 restrictions as of July 21 given the low prevalence of the virus in the territory, but not disregarding epidemiological surveillance and safety protocols.

Alicia Barcena, executive secretary of the Economic Commission for Latin America and the Caribbean (ECLAC), highlighted Cuba's great resilience, despite being subjected for more than 60 years to the largest series of sanctions that the United States has applied to any country in the world.

A total of 2,109,050 Cubans have already completed the three-dose vaccination schedule of one of the vaccine candidates developed in the country against COVID-19.

Cuba studied 43,808 samples of COVID 19, resulting in 6,057 positive ones. The country accumulates 5, 950,808 samples taken and 294,449 positive.

The Abdala vaccine, obtained by the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym), will benefit pregnant women in the second and third trimester of gestation and infants, as well as people allergic to thiomersal in the coming months.

In the midst of an epidemiological context marked by the circulation of new strains in the country, there is evidence of an increase in the severity of COVID-19 in infected patients.

An agreement between the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym) and the University of Havana (UH) will allow the creation of a joint laboratory in Nanobiomedicine, for the execution of innovative projects linked to the design and production of drugs.

The Cuban Finlay Vaccine Institute highlighted the high safety level proven by clinical trials with the COVID-19 candidate vaccine Soberana 02 in Cuban children.

Two million 108 thousand 739 citizens in Cuba have already received all three doses of the locally developed COVID-19 vaccines which have immunized them against the virus.